Annette N. Ratcliff

Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2 + Breast Cancer

Yazan Alwarawrah, Philip F. Hughes, David R. Loiselle et al. · Cell chemical biology · 2016 · 152 citations · Full text

Breast Oncology, Medicine, Mmtv-neu Model +7

Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by a Cyclic Peptide that Binds the Tat-Transactivating Response Element (TAR) RNA

Matthew S. Lalonde, Michael A. Lobritz, Annette N. Ratcliff et al. · PLoS Pathogens · 2011 · 77 citations · Full text

HIV-1 Entry, Inhibitors, and Resistance

Michael A. Lobritz, Annette N. Ratcliff, Eric J. Arts · Viruses · 2010 · 66 citations · Full text

Hiv-1 Entry, Medicine, Virus Entry +14

HIV-1 Resistance to Maraviroc Conferred by a CD4 Binding Site Mutation in the Envelope Glycoprotein gp120

Annette N. Ratcliff, Wuxian Shi, Eric J. Arts · Journal of Virology · 2012 · 54 citations · Full text

Mvc-resistant Variants, Hiv-1 Resistance, Immunology +17

Cellular fatty acid synthase is required for late stages of HIV-1 replication

Manjusha Kulkarni, Annette N. Ratcliff, Menakshi Bhat et al. · Retrovirology · 2017 · 47 citations · Full text